Cargando…
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐2 (SARS‐CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles. Currently, no established intervention has lowered the mortality rate in the “coronavirus disease 2019 (COVID‐19)” patients. Recently, 2...
Autores principales: | Huang, Zoufang, Chavda, Vivek P., Vora, Lalitkumar K., Gajjar, Normi, Apostolopoulos, Vasso, Shah, Nirav, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041304/ https://www.ncbi.nlm.nih.gov/pubmed/35496298 http://dx.doi.org/10.3389/fphar.2022.899633 |
Ejemplares similares
-
Inhalable Vaccines: Can They Help Control Pandemics?
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
por: Chavda, Vivek P., et al.
Publicado: (2021) -
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
por: Chavda, Vivek P., et al.
Publicado: (2022) -
An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care
por: Huang, Zoufang, et al.
Publicado: (2022) -
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer
por: Chavda, Vivek P., et al.
Publicado: (2023)